← SynDRA
NU-7441
SynDRA canonical compound SYN0061358 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PRKDC |
|---|
| Mechanism of action | DNA dependent protein kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- P-glycoprotein inhibitor
- DNA dependent protein kinase inhibitor
- PRKDC INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- NU-7432
- NU7441
- KU 57788
- 8-(4-Dibenzothienyl)-2-(4-morpholinyl)-4H-1-benzopyran-4-one
- 8-dibenzothiophen-4-yl-2-morpholin-4-ylchromen-4-one
- XF6ZJD5WGU
- RefChem:927978
- NU7441 (KU-57788)
- 8-(dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-one
- 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one
- C25H19NO3S
- 2R4
- MFCD11983069
- NU7441(KU-57788)
- UNII-XF6ZJD5WGU
- MLS006011188
- SCHEMBL600096
- GTPL8010
- orb1300912
- SCHEMBL29373835
- SCHEMBL29380743
- SCHEMBL30203800
- CHEBI:91361
- 4o72
- GLXC-03693
- HMS3265K11
- HMS3265K12
- HMS3265L11
- HMS3265L12
- HMS3656N07
- HMS3748A17
- EX-A1331
- BDBM50156495
- s2638
- AKOS024457766
- CCG-268806
- CP-0073
- SB19243
- SDCCGSBI-0654435.P001
Look up NU-7441 in the interactive SynDRA portal →